View in EDS

Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center.

Saved in:
Bibliographic Details
Title: Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center.
Authors: Oran B; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center. boran@mdanderson.org., Thall P; Department of Biostatistics, The University of Texas MD Anderson Cancer Center., Alousi A; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Mehta R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Marin D; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Bassett R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center., Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Im J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Olson A; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Jewell J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Smallbone P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center., Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.
Source: Haematologica [Haematologica] 2026 Jan 01; Vol. 111 (1), pp. 149-157. Date of Electronic Publication: 2025 Jul 24.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40702903
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Oran+B%22">Oran B</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center. boran@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Thall+P%22">Thall P</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Alousi+A%22">Alousi A</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Al-Atrash+G%22">Al-Atrash G</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Mehta+R%22">Mehta R</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Marin+D%22">Marin D</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Kebriaei+P%22">Kebriaei P</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Popat+U%22">Popat U</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Bassett+R%22">Bassett R</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Bashir+Q%22">Bashir Q</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Im+J%22">Im J</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Olson+A%22">Olson A</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Jewell+J%22">Jewell J</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Smallbone+P%22">Smallbone P</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Shpall+E%22">Shpall E</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.<br /><searchLink fieldCode="AU" term="%22Champlin+R%22">Champlin R</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2026 Jan 01; Vol. 111 (1), pp. 149-157. <i>Date of Electronic Publication: </i>2025 Jul 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40702903
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2025.287628
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 149
    Titles:
      – TitleFull: Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Oran B
      – PersonEntity:
          Name:
            NameFull: Thall P
      – PersonEntity:
          Name:
            NameFull: Alousi A
      – PersonEntity:
          Name:
            NameFull: Al-Atrash G
      – PersonEntity:
          Name:
            NameFull: Mehta R
      – PersonEntity:
          Name:
            NameFull: Marin D
      – PersonEntity:
          Name:
            NameFull: Kebriaei P
      – PersonEntity:
          Name:
            NameFull: Popat U
      – PersonEntity:
          Name:
            NameFull: Bassett R
      – PersonEntity:
          Name:
            NameFull: Bashir Q
      – PersonEntity:
          Name:
            NameFull: Im J
      – PersonEntity:
          Name:
            NameFull: Olson A
      – PersonEntity:
          Name:
            NameFull: Jewell J
      – PersonEntity:
          Name:
            NameFull: Smallbone P
      – PersonEntity:
          Name:
            NameFull: Shpall E
      – PersonEntity:
          Name:
            NameFull: Champlin R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 111
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1